Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?

@article{Kraaijeveld2007ChemokinesAA,
  title={Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?},
  author={Adriaan O. Kraaijeveld and Saskia C. A. de Jager and Theo J. C. van Berkel and Erik A. L. Biessen and Jan Wouter Jukema},
  journal={Current pharmaceutical design},
  year={2007},
  volume={13 10},
  pages={
          1039-52
        }
}
Atherosclerosis is currently viewed as an inflammatory disease in which the initiation and progression of the atherosclerotic plaque towards a rupture prone, unstable plaque is driven by leukocyte recruitment mediated by various inflammatory mediators. Recently, interest in chemotactic cytokines or chemokines with regard to atherosclerosis has been growing as chemokines mediate the influx of leukocytes that is typical of atherothrombosis. The activity of the majority of chemokines is… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

Immune and inflammatory mechanisms of atherosclerosis (*).

Annual review of immunology • 2009
View 5 Excerpts
Highly Influenced

PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine • 2016
View 2 Excerpts

Fistular onion stalk extract exhibits anti-atherosclerotic effects in rats

Experimental and therapeutic medicine • 2014
View 1 Excerpt

Similar Papers

Loading similar papers…